Lupin launches generic Tetrabenazine tablets
Pharma major Lupin announced the launch of Tetrabenazine Tablets, 12.5 mg and 25 mg having received an approval from the USFDA earlier.
Lupin’s Tetrabenazine Tablets, 12.5 mg and 25 mg are the generic equivalent of Valeant Pharmaceuticals North America, LLC’s Xenazine tablets. The drug is indicated for the treatment of chorea associated with Huntington’s disease.
Xenazine tablets had annual sales of $153mn in the US (IQVIA MAT September 2018).
Adani Gas bags 13 city gas distribution projects
Adani Gas Ltd, the city gas distribution arm of the Adani Group, has bagged authorization from the Petroleum and Natural Gas Regulatory Board (PNGRB) to expand its city gas footprint in 13 new Geographical Areas (GAs) in the recently concluded 9th round of CGD bidding.
In addition, the company has also won 9 GAs in its joint venture company with Indian Oil Corporation, i.e. Indian Oil - Adani Gas Ltd. (IOAGPL), as per bse press release.
Adani Gas is currently operating CGD network in 4 locations i.e. Ahmedabad, Baroda, Faridabad and Khurja. Its joint venture with IOCL is currently running CGD networks at Prayagraj, Chandigarh, Panipat, Udham Singh Nagar, Daman, Dharwad, Ernakulam, South Goa and Bulandshahr.
Rajesh Exports bags order worth Rs933cr
Rajesh Exports, in a filing to the exchanges on Wednesday, informed that the company has received an order for products valued at Rs933cr. The order is expected to be delivered by March 2019.
The company will be executing the order from its manufacturing facility that has a processing capacity of 250 ton of jewelry and gold products per annum, the company added.
Dr.Reddy’s to re-launch Suboxone in US:
The United States Court of Appeals issued a decision in favor of Dr. Reddy's Laboratories in the case vs. Indivior. This decision will now allow Dr. Reddy's to sell its generic version of Suboxone® (buprenorphine and naloxone) sublingual film. As a result of this ruling, Dr. Reddy's will resume its launch activities as soon as permitted.
A company spokesperson stated, "We are pleased with the decision of the appellate court in Dr. Reddy's favor, vacating the preliminary injunction that had prevented Dr. Reddy's from bringing this important drug to the public."
Minda Corporation to reduce stake in Minda Furukawa from 51% to 25%
Auto ancillary maker, Minda Corporation Limited (MCorp) announced that it will reduce stake in its joint venture (JV) with Furukawa Group of Japan (Furukawa). The JV, called Minda Furukawa Electric Private Limited (MFEPL) is currently owned 51% by MCorp and 49% by Furukawa. Post the restructuring exercise, MCorp will reduce its stake from 51% to 25%, while Furukawa will raise stake from 49% to 75%. The change in equity structure will take place through a mix of sale of shares of MFEPL by MCorp and additional equity infusion into MFEPL by Furukawa.
Financial Advisory Company in Indore, Stock Advisory Company in Indore , Equity Tips , Free Trading Tips , MCX Tips , sebi registered advisory company , Intraday stock tips , Free commodity tips
0 comments:
Post a Comment